SRARP and prostate carcinoma: In addition, the drastic inhibition of Akt protein expression after SRARP overexpression in DU‐145 cell line may be explained by the fact that SRARP‐co‐expressed genes in prostate cancer are associated with the protein ubiquitination pathway that regulates protein degradation (Tables 5 and S7).